 | • レポートコード：MRC2Q12-16820 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、小児成長ホルモン欠乏症のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 小児成長ホルモン欠乏症のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 小児成長ホルモン欠乏症の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 小児成長ホルモン欠乏症のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの小児成長ホルモン欠乏症の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の小児成長ホルモン欠乏症の売上および2028年までの予測に焦点を当てています。 小児成長ホルモン欠乏症のグローバル主要企業には、Novo Nordisk、Eli Lily、Novartis、Merck KGaA、Pfizer、Ferring、Genentech、BioParteners、LG Chem、Ipsen Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 小児成長ホルモン欠乏症市場は、タイプとアプリケーションによって区分されます。世界の小児成長ホルモン欠乏症市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 先天性GH欠損症、後天性GH欠損症、特発性GH欠損症 【アプリケーション別セグメント】 病院薬局、小売店、オンライン薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 小児成長ホルモン欠乏症製品概要 - タイプ別市場（先天性GH欠損症、後天性GH欠損症、特発性GH欠損症） - アプリケーション別市場（病院薬局、小売店、オンライン薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の小児成長ホルモン欠乏症販売量予測2017-2028 - 世界の小児成長ホルモン欠乏症売上予測2017-2028 - 小児成長ホルモン欠乏症の地域別販売量 - 小児成長ホルモン欠乏症の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別小児成長ホルモン欠乏症販売量 - 主要メーカー別小児成長ホルモン欠乏症売上 - 主要メーカー別小児成長ホルモン欠乏症価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（先天性GH欠損症、後天性GH欠損症、特発性GH欠損症） - 小児成長ホルモン欠乏症のタイプ別販売量 - 小児成長ホルモン欠乏症のタイプ別売上 - 小児成長ホルモン欠乏症のタイプ別価格 ・アプリケーション別市場規模（病院薬局、小売店、オンライン薬局、その他） - 小児成長ホルモン欠乏症のアプリケーション別販売量 - 小児成長ホルモン欠乏症のアプリケーション別売上 - 小児成長ホルモン欠乏症のアプリケーション別価格 ・北米市場 - 北米の小児成長ホルモン欠乏症市場規模（タイプ別、アプリケーション別） - 主要国別の小児成長ホルモン欠乏症市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの小児成長ホルモン欠乏症市場規模（タイプ別、アプリケーション別） - 主要国別の小児成長ホルモン欠乏症市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の小児成長ホルモン欠乏症市場規模（タイプ別、アプリケーション別） - 主要国別の小児成長ホルモン欠乏症市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の小児成長ホルモン欠乏症市場規模（タイプ別、アプリケーション別） - 主要国別の小児成長ホルモン欠乏症市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの小児成長ホルモン欠乏症市場規模（タイプ別、アプリケーション別） - 主要国別の小児成長ホルモン欠乏症市場規模（トルコ、サウジアラビア） ・企業情報 Novo Nordisk、Eli Lily、Novartis、Merck KGaA、Pfizer、Ferring、Genentech、BioParteners、LG Chem、Ipsen Pharma ・産業チェーン及び販売チャネル分析 - 小児成長ホルモン欠乏症の産業チェーン分析 - 小児成長ホルモン欠乏症の原材料 - 小児成長ホルモン欠乏症の生産プロセス - 小児成長ホルモン欠乏症の販売及びマーケティング - 小児成長ホルモン欠乏症の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 小児成長ホルモン欠乏症の産業動向 - 小児成長ホルモン欠乏症のマーケットドライバー - 小児成長ホルモン欠乏症の課題 - 小児成長ホルモン欠乏症の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Pediatric Growth Hormone Deficiency estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Pediatric Growth Hormone Deficiency is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Pediatric Growth Hormone Deficiency is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Pediatric Growth Hormone Deficiency is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Pediatric Growth Hormone Deficiency include Novo Nordisk, Eli Lily, Novartis, Merck KGaA, Pfizer, Ferring, Genentech, BioParteners and LG Chem, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pediatric Growth Hormone Deficiency companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Pediatric Growth Hormone Deficiency market. Further, it explains the major drivers and regional dynamics of the global Pediatric Growth Hormone Deficiency market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Novo Nordisk
Eli Lily
Novartis
Merck KGaA
Pfizer
Ferring
Genentech
BioParteners
LG Chem
Ipsen Pharma
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Pediatric Growth Hormone Deficiency Segment by Type
Congenital GH Deficiency
Acquired GH Deficiency
Idiopathic GH Deficiency
Pediatric Growth Hormone Deficiency Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Pediatric Growth Hormone Deficiency market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Pediatric Growth Hormone Deficiency market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Pediatric Growth Hormone Deficiency, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pediatric Growth Hormone Deficiency, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pediatric Growth Hormone Deficiency revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Pediatric Growth Hormone Deficiency market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Pediatric Growth Hormone Deficiency revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Novo Nordisk, Eli Lily, Novartis, Merck KGaA, Pfizer, Ferring, Genentech, BioParteners and LG Chem, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Pediatric Growth Hormone Deficiency in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Growth Hormone Deficiency companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pediatric Growth Hormone Deficiency revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Growth Hormone Deficiency Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Congenital GH Deficiency
1.2.3 Acquired GH Deficiency
1.2.4 Idiopathic GH Deficiency
1.3 Market by Application
1.3.1 Global Pediatric Growth Hormone Deficiency Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Growth Hormone Deficiency Market Perspective (2017-2028)
2.2 Pediatric Growth Hormone Deficiency Growth Trends by Region
2.2.1 Pediatric Growth Hormone Deficiency Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pediatric Growth Hormone Deficiency Historic Market Size by Region (2017-2022)
2.2.3 Pediatric Growth Hormone Deficiency Forecasted Market Size by Region (2023-2028)
2.3 Pediatric Growth Hormone Deficiency Market Dynamics
2.3.1 Pediatric Growth Hormone Deficiency Industry Trends
2.3.2 Pediatric Growth Hormone Deficiency Market Drivers
2.3.3 Pediatric Growth Hormone Deficiency Market Challenges
2.3.4 Pediatric Growth Hormone Deficiency Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Growth Hormone Deficiency Players by Revenue
3.1.1 Global Top Pediatric Growth Hormone Deficiency Players by Revenue (2017-2022)
3.1.2 Global Pediatric Growth Hormone Deficiency Revenue Market Share by Players (2017-2022)
3.2 Global Pediatric Growth Hormone Deficiency Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pediatric Growth Hormone Deficiency Revenue
3.4 Global Pediatric Growth Hormone Deficiency Market Concentration Ratio
3.4.1 Global Pediatric Growth Hormone Deficiency Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Growth Hormone Deficiency Revenue in 2021
3.5 Pediatric Growth Hormone Deficiency Key Players Head office and Area Served
3.6 Key Players Pediatric Growth Hormone Deficiency Product Solution and Service
3.7 Date of Enter into Pediatric Growth Hormone Deficiency Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Growth Hormone Deficiency Breakdown Data by Type
4.1 Global Pediatric Growth Hormone Deficiency Historic Market Size by Type (2017-2022)
4.2 Global Pediatric Growth Hormone Deficiency Forecasted Market Size by Type (2023-2028)
5 Pediatric Growth Hormone Deficiency Breakdown Data by Application
5.1 Global Pediatric Growth Hormone Deficiency Historic Market Size by Application (2017-2022)
5.2 Global Pediatric Growth Hormone Deficiency Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pediatric Growth Hormone Deficiency Market Size (2017-2028)
6.2 North America Pediatric Growth Hormone Deficiency Market Size by Type
6.2.1 North America Pediatric Growth Hormone Deficiency Market Size by Type (2017-2022)
6.2.2 North America Pediatric Growth Hormone Deficiency Market Size by Type (2023-2028)
6.2.3 North America Pediatric Growth Hormone Deficiency Market Share by Type (2017-2028)
6.3 North America Pediatric Growth Hormone Deficiency Market Size by Application
6.3.1 North America Pediatric Growth Hormone Deficiency Market Size by Application (2017-2022)
6.3.2 North America Pediatric Growth Hormone Deficiency Market Size by Application (2023-2028)
6.3.3 North America Pediatric Growth Hormone Deficiency Market Share by Application (2017-2028)
6.4 North America Pediatric Growth Hormone Deficiency Market Size by Country
6.4.1 North America Pediatric Growth Hormone Deficiency Market Size by Country (2017-2022)
6.4.2 North America Pediatric Growth Hormone Deficiency Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pediatric Growth Hormone Deficiency Market Size (2017-2028)
7.2 Europe Pediatric Growth Hormone Deficiency Market Size by Type
7.2.1 Europe Pediatric Growth Hormone Deficiency Market Size by Type (2017-2022)
7.2.2 Europe Pediatric Growth Hormone Deficiency Market Size by Type (2023-2028)
7.2.3 Europe Pediatric Growth Hormone Deficiency Market Share by Type (2017-2028)
7.3 Europe Pediatric Growth Hormone Deficiency Market Size by Application
7.3.1 Europe Pediatric Growth Hormone Deficiency Market Size by Application (2017-2022)
7.3.2 Europe Pediatric Growth Hormone Deficiency Market Size by Application (2023-2028)
7.3.3 Europe Pediatric Growth Hormone Deficiency Market Share by Application (2017-2028)
7.4 Europe Pediatric Growth Hormone Deficiency Market Size by Country
7.4.1 Europe Pediatric Growth Hormone Deficiency Market Size by Country (2017-2022)
7.4.2 Europe Pediatric Growth Hormone Deficiency Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size (2017-2028)
8.2 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size by Type
8.2.1 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Pediatric Growth Hormone Deficiency Market Share by Type (2017-2028)
8.3 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size by Application
8.3.1 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Pediatric Growth Hormone Deficiency Market Share by Application (2017-2028)
8.4 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size by Region
8.4.1 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Pediatric Growth Hormone Deficiency Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Pediatric Growth Hormone Deficiency Market Size (2017-2028)
9.2 Latin America Pediatric Growth Hormone Deficiency Market Size by Type
9.2.1 Latin America Pediatric Growth Hormone Deficiency Market Size by Type (2017-2022)
9.2.2 Latin America Pediatric Growth Hormone Deficiency Market Size by Type (2023-2028)
9.2.3 Latin America Pediatric Growth Hormone Deficiency Market Share by Type (2017-2028)
9.3 Latin America Pediatric Growth Hormone Deficiency Market Size by Application
9.3.1 Latin America Pediatric Growth Hormone Deficiency Market Size by Application (2017-2022)
9.3.2 Latin America Pediatric Growth Hormone Deficiency Market Size by Application (2023-2028)
9.3.3 Latin America Pediatric Growth Hormone Deficiency Market Share by Application (2017-2028)
9.4 Latin America Pediatric Growth Hormone Deficiency Market Size by Country
9.4.1 Latin America Pediatric Growth Hormone Deficiency Market Size by Country (2017-2022)
9.4.2 Latin America Pediatric Growth Hormone Deficiency Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size (2017-2028)
10.2 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size by Type
10.2.1 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Pediatric Growth Hormone Deficiency Market Share by Type (2017-2028)
10.3 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size by Application
10.3.1 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Pediatric Growth Hormone Deficiency Market Share by Application (2017-2028)
10.4 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size by Country
10.4.1 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Pediatric Growth Hormone Deficiency Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Details
11.1.2 Novo Nordisk Business Overview
11.1.3 Novo Nordisk Pediatric Growth Hormone Deficiency Introduction
11.1.4 Novo Nordisk Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.1.5 Novo Nordisk Recent Developments
11.2 Eli Lily
11.2.1 Eli Lily Company Details
11.2.2 Eli Lily Business Overview
11.2.3 Eli Lily Pediatric Growth Hormone Deficiency Introduction
11.2.4 Eli Lily Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.2.5 Eli Lily Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Pediatric Growth Hormone Deficiency Introduction
11.3.4 Novartis Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.3.5 Novartis Recent Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Pediatric Growth Hormone Deficiency Introduction
11.4.4 Merck KGaA Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.4.5 Merck KGaA Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Pediatric Growth Hormone Deficiency Introduction
11.5.4 Pfizer Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.5.5 Pfizer Recent Developments
11.6 Ferring
11.6.1 Ferring Company Details
11.6.2 Ferring Business Overview
11.6.3 Ferring Pediatric Growth Hormone Deficiency Introduction
11.6.4 Ferring Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.6.5 Ferring Recent Developments
11.7 Genentech
11.7.1 Genentech Company Details
11.7.2 Genentech Business Overview
11.7.3 Genentech Pediatric Growth Hormone Deficiency Introduction
11.7.4 Genentech Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.7.5 Genentech Recent Developments
11.8 BioParteners
11.8.1 BioParteners Company Details
11.8.2 BioParteners Business Overview
11.8.3 BioParteners Pediatric Growth Hormone Deficiency Introduction
11.8.4 BioParteners Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.8.5 BioParteners Recent Developments
11.9 LG Chem
11.9.1 LG Chem Company Details
11.9.2 LG Chem Business Overview
11.9.3 LG Chem Pediatric Growth Hormone Deficiency Introduction
11.9.4 LG Chem Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.9.5 LG Chem Recent Developments
11.10 Ipsen Pharma
11.10.1 Ipsen Pharma Company Details
11.10.2 Ipsen Pharma Business Overview
11.10.3 Ipsen Pharma Pediatric Growth Hormone Deficiency Introduction
11.10.4 Ipsen Pharma Revenue in Pediatric Growth Hormone Deficiency Business (2017-2022)
11.10.5 Ipsen Pharma Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer